共 27 条
[1]
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up
[J].
BLOOD,
2002, 100 (09)
:3141-3146
[3]
CORDONNIER C, 1985, CANCER-AM CANCER SOC, V55, P18, DOI 10.1002/1097-0142(19850101)55:1<18::AID-CNCR2820550104>3.0.CO
[4]
2-B
[7]
DOMBRET H, 1992, LEUKEMIA, V6, P1237
[8]
DOMBRET H, 1993, LEUKEMIA, V7, P2